Abstract:IntroductionThere are large differences between the prenatal screening strategies for Down Syndrome (DS) in different provinces in China. In Henan province there is a serological triple screening in the second trimester (STS) strategy, while in Shandong province contingent non-invasive prenatal testing (NIPT) screening strategy (NIPT delivered to older pregnant women) is used, and there is a universal NIPT screening strategy in Anhui province. Moreover, many factors varied widely in different regions, such as the proportion of older pregnant woman and the ability of people to pay. This study aimed to determine the cost-effectiveness of current strategy in Shandong compared with strategies in other provinces.MethodsA decision tree model was developed according to the screening strategies in different provinces. Four screening strategies were involved, universal STS strategy, contingent STS strategy, contingent NIPT strategy, and universal NIPT strategy. Cost-effectiveness analysis was conducted from a societal perspective in a simulated cohort of 100,000 pregnant women. The data of costs and epidemiologic parameters were collected from field surveys in Shangdong and a literature review.ResultsThe universal STS strategy, contingent STS strategy, contingent NIPT strategy, and universal NIPT strategy could prevent 17.0, 40.0, 46.2, and 53.6 DS births, respectively. There was no strategy dominated by others. The universal NIPT strategy and contingent NIPT strategy would decrease invasive procedures for prenatal diagnosis, resulting in fewer procedure-related miscarriages. The sensitivity analysis showed that the effectiveness of the screening strategy is significantly influenced by the resident's acceptance of NIPT.ConclusionsFrom the perspective of maximizing the effect, the universal NIPT strategy is the optimal strategy. But taking into account the resident's and government's ability to pay, contingent NIPT Strategy may be appropriate for the current situation in Shandong. To ensure a better cost-effective advantage in the universal NIPT strategy, the government should provide health education to increase the acceptance of NIPT while controlling the price of NIPT.

International experience of informed consent and genetic counseling on non-invasive prenatal testing applied in Down syndrome prenatal screening

International experience of clinical practice of non-invasive prenatal testing

Ethical considerations of non-invasive prenatal testing in Down syndrome prenatal clinical practice

Clinical application of noninvasive prenatal testing for the detection of trisomies 21, 18, and 13: a hospital experience.

Chinese geneticists' views of ethical issues in genetic testing and screening: evidence for eugenics in China

Research Progress and Challenges of Preimplantation Genetic Testing for Polygenic Diseases.

Introducing the non-invasive prenatal testing for detection of Down syndrome in China: a cost-effectiveness analysis

Evidence of compliance with and effectiveness of guidelines for noninvasive prenatal testing in China: a retrospective study of 189,809 cases

[Expert consensus on the clinical application strategy of NIPT2.0, a new-generation non-invasive prenatal screening technology]

Qualitative Analysis of Implementation and Governmental Regulation of Non-Invasive Prenatal Testing in China

Understanding Knowledge, Perception, and Willingness of Non-Invasive Prenatal Testing for Fetal Aneuploidy: a Survey among Chinese High-Risk Pregnant Women

Non-Invasive Prenatal Screening from a Genetic Counseling Prospective: Pre and Post-Genetic Counseling Regarding Rare Chromosomal Abnormalities and Incidental Finding

Ethical Challenges in Information Disclosure and Decision-making in Prenatal Testing: A Focus Group Study of Chinese Health Professionals in Maternal and Child Health Services

The Application of NIPT Using Combinatorial Probe-Anchor Synthesis to Identify Sex Chromosomal Aneuploidies (scas) in a Cohort of 570 Pregnancies

Physicians' Perception Toward Non-Invasive Prenatal Testing Through the Eye of the Rogers' Diffusion of Innovation Theory in China

OP354 Cost-Effectiveness Analysis of Different Prenatal Screening Strategies for Down Syndrome in China: Data from Shandong Province

Development of Preimplantation Genetic Testing for Monogenic Diseases in China

Economic Evaluation of Prenatal Diagnosis Intervention for Down's Syndrome in China

Performance evaluation of noninvasive prenatal testing on 24 chromosomes in a cohort of 118,969 pregnant women in Sichuan, China

Cost-Effectiveness Analysis Of Prenatal Diagnosis Intervention For Down'S Syndrome In China

The Knowledge, Attitude, Practices, and Satisfaction of Non-Invasive Prenatal Testing among Chinese Pregnant Women under Different Payment Schemes: A Comparative Study